In the realm of personalized medicine, understanding the unique genetic makeup of an individual’s cancer has become paramount in tailoring treatment options. One such marker that has garnered attention is the Programmed Death-Ligand 1 (PD-L1) protein, which plays a significant role in suppressing the immune system during various processes such as pregnancy, tissue allografts, and […]











